Erectile dysfunction

Advances in Psychosomatic Medicine

Volumn 29, Issue , 2008, Pages 33-49

  Wylie, K ^a  

^a Nether Edge Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR;

ADULT; BEHAVIOR THERAPY; COMORBIDITY; DEPRESSION; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; HEALTH STATUS; HUMAN; HUMAN RELATION; HYPOGONADISM; LIBIDO; LIFESTYLE; MALE; METHODOLOGY; MIDDLE AGED; PENIS ERECTION; PEYRONIE DISEASE; PSYCHOLOGICAL ASPECT; REVIEW; SEXUAL COUNSELING; SEXUALITY; URINARY TRACT DISEASE;

ADULT; BEHAVIOR THERAPY; COMORBIDITY; DEPRESSION; ERECTILE DYSFUNCTION; EVIDENCE-BASED MEDICINE; HEALTH STATUS; HUMANS; HYPOGONADISM; INTERPERSONAL RELATIONS; LIBIDO; LIFE STYLE; MALE; MIDDLE AGED; PENILE ERECTION; PENILE INDURATION; PHOSPHODIESTERASE INHIBITORS; RESEARCH DESIGN; SEX COUNSELING; SEXUAL PARTNERS; UROLOGIC DISEASES;

EID: 46449091296     PISSN: 00653268     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000126623     Document Type: Review

References (87)

1. Russell ST, Khandheria B, Nehra A: Erectile Dysfunction and Cardiovascular Disease. Mayo Clin Proc 2004;79:782-794.
2. Haczynksi J, Lew-Starowicz Z, Darewicz B, Krajka K, Piotrowicz R, Ciesielska B: The prevalence of erectile dysfunction in men visiting out patient clinics. Int J Impot Res 2006;18:359-363.
3. DeBusk R, Drory Y, Goldstein I, Jackson G, Kaul S: Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus Panel. Am J Cardiol 2000;86:2, 175-181.
4. Seidman SN: Exploring the relationship between depression and erectile dysfunction in aging men. J Clin Psychiatry 2002;63:5, 5-12.
5. Nicolosi A, et al: Sexual behaviour and sexual dysfunctions after age 40: the global study of sexual attitudes and behaviours. J Urol 2004;64:991-997.
6. Wylie KR, DeColomby P, Giami A: Sexology as a profession in the United Kingdom. Int J Clin Pract 2004;58:764-768.
7. Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
8. Burnett AL: Erectile dysfunction; science and medicine. Annu Rev Sex Res 2006;17:101-115.
9. Sáenz de Tejada, Angulo J, Cellek S, González-Cadavid N, Heaton J, Pickard R, Simonsen U: Physiology of erectile function. J Sex Med 2004;1:254-265.
10. Jin L, Burnett AL: RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. Clin Sci 2006;110:153-165.
11. Schwarz ER, Rastogi S, Kapur V, Sulemanjee N, Rodriquez JJ: Erectile dysfunction in heart failure patients. J Am Coll Cardiol 2006;48:6, 1111-1119.
12. Vacanti L, Caramelli B: Distress: Associated variables of erectile dysfunction post acute myocardial infarction. Pilot study. Int J Impot Res 2005;17:204-206.
13. Gazzaruso C, Giordanetti S, DeAmici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A: Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004;110:22-26.
14. Wang BC, Cunningham G, Dobs A, Iranmanesh A: Is atherosclerotic cardiovascular disease an endocrinological disorder? J Clin Endocrinol Metab 2004;89:2085-2098.
15. Barrett-Connor E, Goodman-Gruen D, Patay P: Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 1999;84:3681-3685.
16. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C 3rd, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R: Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005;96:313-321.
17. Montorsi P: Is erectile dysfunction the 'tip of the iceberg' of a systemic vascular disorder? Eur Urol 2003;44:3, 352.
18. Carani C, Isidori A, Granata A: Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Endocrinol Clin Metab 2005;90:6472-6479.
19. Seftel A, Sun P, Swindle R: The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004; 171:2341-2345.
20. Boersma SN, Maes S, van Elderen T: Goal disturbance predicts health-related quality of life and depression four months after myocardial infarction. Br J Health Psychol 2005;10:615-630.
21. Rastogi S, Rodriguez JJ, Kapur V, Schwarz ER: Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem. Int J Impot Res 2005;17:S25-S36.
22. Soloman H, DeBusk R, Jackson G: Erectile dysfunction: the need to be evaluated, the right to be treated. Am Heart J 2005;150:4, 620-626.
23. Rerkpattanapipat P, Stanek MS, Kotler MN: Sex and the heart: what is the role of the cardiologist? Eur Heart J 2001;22:3, 201-208.
24. Haboubi NHJ, Lincoln N: Views of health professionals on discussing sexual issues with patients. Disabil Rehabil 2003;25:291-296.
25. Enzlin P, Mak R, Kittel F, Demyttenaere K: Sexual functioning in a population-based study of men aged 40-69 years: the good news. Int J Impot Res 2004;16:512-520.
26. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ: A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762-774.
27. Humphrey S, Nazareth I: GP's views on their management of sexual dysfunction. Fam Pract 2001;18:516-518.
28. Rele K, Wylie K: Management of psychosexual and relationship problems in general mental health services by psychiatry trainees. Int J Clin Pract 2007;61:10, 1701-1704.
29. Gott M, Galena E, Hinchliffe S, Elford H: 'Opening a Can of Worms': GP and practice nurse barriers to talking about sexual health in Primary Care. Fam Pract 2004;21:5, 528-536.
30. Wylie KR, Davies-South D, Steward D, Walters S, Iqbal M, Ryles SA: comparison between portable ultrasound (MIDUS) and nocturnal RigiScan when confirming the diagnosis of vascular organic erectile disorder. Int J Impot Res 2006;18:354-358.
31. Wylie KR, Hallam-Jones R, Perrett A: Some of the potential implications of integrated assessment for male erectile disorder. Sex Marital Ther 1999;14:359-369.
32. Rosen RC, et al: The International Index of Erectile Dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. J Urol 1997;49:822-830.
33. Sharne DH: Erectile dysfunction in obese men (letter). JAMA 2004;292:2467.
34. Esposito K, Marfella R, Ciotola M, Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome. JAMA 2004;292:1440-1446.
35. Perimenis P, Karkoulias K, Markou S, Gyftopoulos K, Athanasopoulos A, Barbalias G, Kiriazopoulou V, Spiropoulos K: The efficacy of sildenafil and continuous positive airway pressure. Int J Importance Res 2004;16:256-260.
36. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C: Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 2007;52:1590-1600.
37. Esposito K, Ciotola M, Giugliano F, De Sio M, Giugliano G, D'Armiento M, Giugliano D: Mediterrean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 2006;18:405-410.
38. Lam TH, Adbullah ASM, Ho LM, Yip AWC, Fan S: Smoking and sexual dysfunction in Chinese males: findings from men's health survey. Int J Impot Res 2006;18:364-369.
39. Horvath KJ, Calsyn DA, Terry C, Cotton A: Erectile dysfunction medication use among men seeking substance abuse treatment. J Addict Disord 2007;26:7-13.
40. Wylie K, Machin A: Erectile dysfunction. Prim Psychiatry 2007;14:2, 65-71.
41. Melnik T, Soares BGO, Nasselo AG: Psychosocial interventions for erectile dysfunction. Cochrane Database Syst Rev 2007. Art. No.: CD004825. DOI: 10.1002/14651858.CD004825.pub2.
42. Bannowsky A, Hautmann S, Wefer B, Schulze H, Van der Horst C, Seif C, Braun PM, Juenemann KP: Nightly low-dose sildenafil improves recovery of erectile function after nerve-sparing radical prostatectomy. Eur Urol Suppl 2006;5:141.
43. Stockman A, Sharpe LT, Tufail PD, Kell C, Ripamonti C, Jeffery G: The effect of sildenafil citrate Viagra on visual sensitivity. J vis 2007;7:4.
44. Shabsigh R, Duval S, Shah M, Regan TS, Juhasz M, Veltry LG: Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data. Curr Med Res Opin 2007;23:10, 2453-2460.
45. Demir E, Balal M, Paydas S, Sertdemir Y, Erken U: Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction. Transplant Proc 2006;38:1379-1381.
46. Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wilkins HJ, Wachs BH, for the Vardenafil Study Group: Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Am Acad Neurol 2006;66:210-216.
47. Porst H, Sharlip ID, Hatzichristou D, Rubio-Aurioles E, Gittelman M, Stancil B, Smith PM, Wilkins HJ, Pommerville P: Extended duration of efficacy of vardenafil when taken 8hours before intercourse: a randomised, double-blind, placebo-controlled study. J Eur Urol 2006;50:1086-1095.
48. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y, EAU: EAU Guidelines on erectile dysfunction: an update. Eur Urol 2006;49:806-815.
49. Wylie KR, MacInnes I: Erectile Dysfunction; in Balon R, Segraves T (eds): Handbook of sexual dysfunction. Boca Raton, Taylor & Francis, 2005.
50. Vardi M, Nini A: Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus. Cochrane Database Syst Rev 2007. Art. No.: CD002187. DOI: 10.1002/14651858.CD002187.pub3.
51. Gorkin L, Hvidsten K, Sobel RE, Siegel R: Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract 2006;60:500-503.
52. Rosen R, Goldstein I, Huang X, Bangerter K, Taylor T: The Treatment Satisfaction Scale (TTS) is a sensitive measure of treatment effectiveness for both patients and partners: results of a randomised controlled trial with vardenafil. Int Soc Sex Med 2007;4:1009-1021.
53. Eardley I, Mirone V, Montorsi F, Ralph D, Kell P, Warner MR, Zhao Y, Beardsworth A: An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy. BJU Int 2005;96:1323-1332.
54. Rubio-Aurioles E, Porst H, Eardley I, Goldstein I: Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study. J Sex Med 2006;3:1037-1049.
55. Tolrà JR, Campaña JMC, Ciutat LF, Miranda EF: Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors. J Sex Med 2006;3:901-909.
56. Moore RA, Derry S, McQuay HJ: Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction. BMC Urol 2005;5:18.
57. Padma-Nathan H, Stecher VJ, Sweeney M, Orazem J, Tseng LJ, Deriesthal H: Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial. Urology 2003;62:400-403.
58. Lisa R, Taylor M, Hawton K: Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev 2004. Art. No.:CD003382. DOI: 10.1002/ 14651858.CD0033 82.pub2.
59. Tharyan P, Gobalakrishanan G: Erectile dysfunction. Clin Evid 2006;15:1-24.
60. Bhasin S, Cunningham GR, Hayes F J, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM: Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:6, 1995-2010.
61. Zitzmann M, Depenbusch M, Gromoll J, Nieschlag E: Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study. J Clin Endocrinol Metab 2003;88:5, 2049-2054.
62. Yassin AA, Saad F: Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate. Asian J Androl 2006;8:3-9.
63. Bolona E, Uraga M, Haddad R, Tracz M, Sideras K, Kennedy CC, Caples S, Erwin P, Montori VM: Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007;82:20-28.
64. Greco E, Spera G, Aversa A: Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. Eur Urol 2006;50:940-947.
65. Saad F, Grahl AS, Aversa A, Yassin AA, Kadioglu A, Moncada I, Eardley I: Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJU Int 2007;99:988-992.
66. Yassin AA, Saad F, Traish A: Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports. J Sex Med2006;3:727-735.
67. Morgentaler A: Testosterone and prostate cancer: an historical perspective on a modern myth. Eur Urol 2006;50:935-939.
68. Traish AM, Guay AT: Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 2006; 3:382-407.
69. Svartberg J: Epidemiology: testosterone and the metabolic syndrome. Int J Impot Res 2007;19:124-128.
70. Ponholzer A, Madersbacher S: Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment. Int J Impot Res 2007;19:544-550.
71. Cameron A, Tomlin M: The effect of male erectile dysfunction on the psychosocial, relationship, and sexual characteristics of heterosexual women in the United States. J Sex Martial Ther 2007;33: 135-149.
72. Wylie KR, Eardley I: Penile size and the 'small penis syndrome'. BJUI 2007;1449-1455.
73. Klotz T, Mathers M, Klotz R, Sommer F: Why do patients with erectile dysfunction abandon effective therapy with Sildenafil? Int J Impot Res 2005;17:2-4.
74. Kendirci M, Tanriverdi O, Trost L, Hellstrom WJ: Management of sildenafil treatment failures. Curr Opin Urol 2006;16:449-459.
75. Gruenwald I, Shenfeld O, Chen J, Raviv G, Richter S, Cohen A, Vardi Y: Positive effect of counselling and dose adjustment in patients with erectile dysfunction who failed treatment with sildenafil. Eur Urol 2006;50:134-140.
76. Althof SE: Sex therapy in the age of pharmacotherapy. Annu Rev Sex Res 2006.
77. McVary KT: Smoking and erectile dysfunction: evidence best analysis. J Urol 2001;166:1624-1632.
78. Shirir R, Koskimäki J, Hakama M, Häkkinen J: Effective lifestyle factors on incidents of erectile dysfunction. Int J Impot Res 2004;16:389-394.
79. Eposito K: Effective lifestyle changes on erectile dysfunction in obese men. A randomised controlled trial. JAMA 2004;291:2978-2904.
80. Nikoobakht M, Nasseh H, Pourkasmaee M: The relationship between lipid profile and erectile dysfunction. Int Importance Res 2005;17:523-526.
81. Rizvi K, Hampson JP, Harvey JN: Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract 2002;19:95-98.
82. McCullough AR, Barada JH, Fawzy A, Guay AT, Hatzichristou D: Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. J Urol 2002;60:28-38.
83. Sommer F, Schulze W: Treating erectile dysfunction by endotherlial rehabilitation with PDE5 inhibitors. World J Urol 2005;23:385-392.
84. Schwartz EJ, Wong P, Graydon RJ: Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004;171:771-774.
85. Kendirci M, Teloken P, Champion H, Hellstrom W, Bivalacqua T: Gene therapy for erectile dysfunction: fact or fiction? Eur Urol 2006;50:1208-1222.
86. Rosenbaum TY: Pelvic floor involvement in male and female sexual dysfunction and the role of pelvic floor rehabilitation in treatment: a literature review. J Sex Med 2007;4:4-13.
87. Nickel M, Moleda D, Loew T, Rother W, Gil FP: Cabergoline treatment in men with psychogenic erectile dysfunction: a randomised, double-blind, placebo-controlled study. Int J Importance Res 2007;19:104-107.